Brain Tumours

Brain metastases

Difficult to draw conclusions from small trials

OS no different in pooled analysis – possible improvement in FIS and reduction of neurological deaths Pts likely to benefit: young age, good neurological function and controlled primary disease

Decision should be made in MDT